Asabys Partners

Asabys Partners is a prominent venture capital firm based in Barcelona, Spain, dedicated to fostering innovation within the European healthcare sector. The firm strategically invests in early-stage companies across a spectrum of critical areas, including biotech, medical technology, digital health, and health services. Their core mission revolves around identifying and supporting disruptive technologies and business models that possess the potential to address significant unmet medical needs or substantially enhance healthcare outcomes. Asabys Partners plays a crucial role in bridging the gap between scientific breakthroughs and market-ready solutions, particularly within the vibrant Spanish and broader European innovation ecosystems.

The firm manages two significant funds, underscoring its growing influence in the healthcare investment landscape. Their inaugural fund, Sabadell Asabys Health Innovation Investments SCR, SA, successfully raised €80 million. Building on this foundation, Asabys Partners recently closed its second fund, Sabadell Asabys II Health Innovation Investments SCR, SA, at an impressive €200 million in July 2023. This substantial increase in capital demonstrates strong investor confidence in their investment strategy and their ability to identify promising ventures. These funds enable Asabys to support companies from Seed stage through Series A and Series B rounds, providing crucial capital at various points in a company's early development.

For companies seeking initial funding, Asabys Partners typically provides first cheques ranging from €3 million to €10 million, specifically from their second fund. This substantial initial investment allows portfolio companies to achieve significant milestones and accelerate their growth. Beyond the initial capital injection, Asabys is known for its commitment to providing follow-on investments, ensuring continued support as companies mature and require additional funding rounds. Their hands-on approach and deep industry expertise make them a strategic partner for healthcare startups aiming to make a tangible impact on global health.